Works matching IS 25233548 AND DT 2021 AND VI 41 AND IP 1
Results: 8
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation.
- Published in:
- Cancer Communications, 2021, v. 41, n. 1, p. 83, doi. 10.1002/cac2.12124
- By:
- Publication type:
- Article
All‐trans retinoic acid induces leukemia resistance to NK cell cytotoxicity by down‐regulating B7‐H6 expression via c‐Myc signaling.
- Published in:
- Cancer Communications, 2021, v. 41, n. 1, p. 51, doi. 10.1002/cac2.12121
- By:
- Publication type:
- Article
CircBA1 derived from BCR‐ABL fusion gene inhibits cell proliferation in chronic myeloid leukemia.
- Published in:
- Cancer Communications, 2021, v. 41, n. 1, p. 79, doi. 10.1002/cac2.12120
- By:
- Publication type:
- Article
Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?
- Published in:
- Cancer Communications, 2021, v. 41, n. 1, p. 3, doi. 10.1002/cac2.12118
- By:
- Publication type:
- Article
The EGFR‐P38 MAPK axis up‐regulates PD‐L1 through miR‐675‐5p and down‐regulates HLA‐ABC via hexokinase‐2 in hepatocellular carcinoma cells.
- Published in:
- Cancer Communications, 2021, v. 41, n. 1, p. 62, doi. 10.1002/cac2.12117
- By:
- Publication type:
- Article
Development and validation of a web‐based calculator to predict individualized conditional risk of site‐specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases.
- Published in:
- Cancer Communications, 2021, v. 41, n. 1, p. 37, doi. 10.1002/cac2.12113
- By:
- Publication type:
- Article
New insights into molecules and pathways of cancer metabolism and therapeutic implications.
- Published in:
- Cancer Communications, 2021, v. 41, n. 1, p. 16, doi. 10.1002/cac2.12112
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Communications, 2021, v. 41, n. 1, p. 1, doi. 10.1002/cac2.12065
- Publication type:
- Article